Loading
British researchers say cures from embryonic stem-cell research unlikely

.- One week after the European Union voted to approve funding for embryonic stem-cell research through 2013, two leading British scientists say that any potential cures from embryonic stem cell research are many years away, if ever they occur, reported LifeNews. They say media and lawmakers, who want funding for the controversial research, have managed to distort public opinion.

Professor Colin McGuckin, a specialist in regenerative medicine at Newcastle University, says the potential for embryonic stem-cell research to cure diseases like Alzheimer's and Parkinson's disease had been exaggerated.

He also said funding is being mismanaged. He believes more funds should be directed for resolving basic health problems, such as infectious diseases which are killing millions of people in developing countries, rather than for speculative fields like embryonic stem-cell research.

Dr. Stephen Minger, director of the Stem Cell Biology Laboratory at King's College in London, has said people should not have false expectations that these therapies are just around the corner. In fact, he said much more "fundamental research" is needed before embryonic stem cells can ever come close to actually helping patients.

An editorial in the L’Osservatore Romano last week, called the EU decision to approve funding for embryonic stem-cell research “macabre product of a twisted sense of progress.”

Henrick Lesaar, director of legal affairs at the Brussels-based Commission for Catholic Bishops' Conferences in the EU, agrees with the editorial.  

“The funding of stem-cell research with stem-cell lines derived from human embryos will give an incentive to destroy human embryos for the purpose of deriving these stem-cell lines,” he told Vatican Radio. He encouraged European citizens, and Catholics especially, to engage in the public debate and to contact their parliamentarians, underlining the anthropological and the ethical considerations for these kinds of decisions.



Ads by AdsLiveMedia.com

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Featured Videos

Heroic Newssub demo_Matt Williamson
Heroic Newssub demo_Matt Williamson
Denver women's clinic will offer natural, Catholic care
Interview Clips: Barbara Nicolosi speaks to CNA
US Cardinals press conference at North American College
Pope Benedict to retire to monastery inside Vatican City
Pope cites waning strength as reason for resignation
Hundreds convene in Denver to urge respect for life
New Orange bishop encourages Catholic unity in diversity
Chinese pro-life activist calls for reform, international attention
At Lincoln installation, Bishop Conley says holiness is success
Mother Cabrini shrine reopens in Chicago after a decade
Ordination of 33 deacons fills St. Peter's with joy
Cardinal says "Charity is the mother of all the virtues"
Augustine Institute expands evangelization effort with new campus
Bishops recall 'Way of St. James' as chance to trust in God
Los Angeles cathedral's newest chapel houses Guadalupe relic
Lay missionaries to the poor open new Denver headquarters
New Buffalo bishop stresses need for modern-day martyrs
Guadalupe message resounds at Los Angeles' massive Marian festival
Pastors of Aurora churches comfort, encourage parishioners
May
19

Liturgical Calendar

May 19, 2013

Pentecost Sunday

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

John 20,19-23

Gospel
Date
05/19/13
05/18/13
05/17/13

Daily Readings


First Reading:: Acts 2:1-11
Second Reading:: 1 Cor 12:3b-7, 12-13
Gospel:: Jn 20:19-23

Saint of the Day

St. Ives »

Saint
Date
05/19/13
05/17/13

Homily of the Day

John 20,19-23

Homily
Date
05/19/13
05/18/13
05/17/13

Ads by AdsLiveMedia.com

Ads by AdsLiveMedia.com
     HTML
Text only
Headlines
  

Follow us: